PILOT Phase: BPD Study
PILOT Study: Treatment of Borderline Personality Disorder by Targeting Ventrolateral Prefrontal-amygdala Circuit With Network-based Neuronavigated Transcranial Magnetic Stimulation
1 other identifier
interventional
20
1 country
1
Brief Summary
This pilot study aims to identify the area of the brain best suited for the treatment of Borderline Personality disorder (BPD). The study investigators will test whether repetitiveTranscranial Magnetic Stimulation (rTMS), a gentle non-invasive brain stimulation method, can improve regulation of emotions and impulsivity in individuals with BPD. This study will enroll up to 20 participants. Participant will be consented for the study remotely via a secure internet platform called Zoom. Participants will undergo 1 Magnetic Resonance Imaging or MRI scan and up to 3 brain stimulation of transcranial magnetic stimulation or TMS sessions, and cognitive behavioral testing on a computer. Participants will complete 4 in-person visits over the course of up to 3 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2024
CompletedFirst Submitted
Initial submission to the registry
October 27, 2025
CompletedFirst Posted
Study publicly available on registry
November 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
February 3, 2026
January 1, 2026
4 years
October 27, 2025
January 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Delay Discounting Task (Odum, 2011)
The Delay Discounting Task (DDT) is cognitive behavioral task performed to evaluate how individuals value rewards over time. It measures the tendency of individuals to prefer smaller, immediate rewards over larger, delayed ones. This behavior is known as delay discounting.
Baseline, Visit 4 (up to 3 weeks)
Cognitive Reappraisal of Social Exclusion Pain Task (Zhao et al., 2021)
This task involves a comparison between a social exclusion group and a social inclusion group, and uses a pain-induction or pain-stimulus paradigm to measure the effects of social exclusion on individuals' perception and regulation of pain
Baseline, Visit 4 (up to 3 weeks)
Study Arms (1)
Stimulation to Ventrolateral Prefrontal Cortex
EXPERIMENTALEach subjects will receive Transcranial Magnetic Stimulation or TMS to 3 different brain regions in 3 separate study visits spaced by at least 4 days (order randomized and counterbalanced amongst subjects). 1. Right Ventrolateral Prefrontal Cortex or VLPFC 2. Left VLPFC 3. Bilateral: left and right VLPFC within 1 session The experimenters will utilize the MagVenture MagPro X100 stimulator equipped with the Cool B70 coil stimulate The TMS protocol includes 1800 pulses of excitatory intermittent theta burst stimulation (iTBS) at 120% MT intensity. This protocol will take less than 9 minutes (for each target).
Interventions
Transcranial magnetic stimulation (TMS) is a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain to improve symptoms of depression. Using pulsed magnetic fields, transcranial magnetic stimulation therapy stimulates the part of the brain thought to be involved with mood regulation. These magnetic fields do not directly affect the whole brain; they only reach about 2-3 centimeters into the brain directly beneath the treatment coil.As these magnetic fields move into the brain, they produce very small electrical currents. These electrical currents activate cells within the brain, causing them to rewire, a process called neuroplasticity.
Eligibility Criteria
You may qualify if:
- Age of 18-65
- DSM-5 Diagnosis of Borderline Personality Disorder (BPD) based upon a psychiatric evaluation and ZAN-BPD scale
- Fluent English speaker
- Ability to give informed consent
You may not qualify if:
- Medical conditions that prevent TMS or MRI to be performed safely upon evaluation by the study psychiatrist
- Active alcohol or drug abuse of such severity that it would pose a risk for TMS administration (i.e., unstable motor thresholds or increased risk for seizure)
- Active suicidal plan
- Current diagnosis of Psychotic or Bipolar disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Semel Institute/ UCLA TMS
Los Angeles, California, 90024, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 27, 2025
First Posted
November 3, 2025
Study Start
January 5, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
February 3, 2026
Record last verified: 2026-01